IPO Details
| IPO Date | November 21, 2025 to November 25, 2025 |
| Listing Date | November 28, 2025 |
| Face Value | ₹1 per share |
| Issue Price Band | ₹563 to ₹593 per share |
| Issue Price Final | ₹593 per share |
| Lot Size | 25 Shares |
| Sale Type | Fresh Capital-cum-Offer for Sale |
| Total Issue Size | 1,50,92,749 shares (aggregating up to ₹895.00 Cr) |
| Fresh Issue | 16,02,023 shares (aggregating up to ₹95.00 Cr) |
| Offer for Sale | 1,34,90,726 shares of ₹1 (aggregating up to ₹800.00 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 11,13,46,602 shares |
| Share Holding Post Issue | 11,29,48,625 shares |
IPO Subscription Details
| Anchor Investors | 1 |
| QIB (Ex Anchor) | 213.08 |
| Non-Institutional Buyers | 116.72 |
| bNII (bids above ₹10L) | 134.91 |
| sNII (bids below ₹10L) | 80.33 |
| Retail Investors | 15.65 |
| Total ** | 93.71 |
IPO Important Dates
| IPO Open Date | Fri, Nov 21, 2025 |
| IPO Close Date | Tue, Nov 25, 2025 |
| Tentative Allotment | Wed, Nov 26, 2025 |
| Initiation of Refunds | Thu, Nov 27, 2025 |
| Credit of Shares to Demat | Thu, Nov 27, 2025 |
| Tentative Listing Date | Fri, Nov 28, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on Tue, Nov 25, 2025 |
IPO Lot Size
| Retail (Min) | 1 | 25 | ₹14,825 |
| Retail (Max) | 13 | 325 | ₹1,92,725 |
| S-HNI (Min) | 14 | 350 | ₹2,07,550 |
| S-HNI (Max) | 67 | 1,675 | ₹9,93,275 |
| B-HNI (Min) | 68 | 1,700 | ₹10,08,100 |
Financial Information
| Period Ended | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 |
| Assets | 922.26 | 717.17 | 513.87 |
| Total Income | 130.08 | 511.33 | 465.38 |
| Profit After Tax | 31.27 | 138.69 | 133.15 |
| EBITDA | 48.57 | 199.28 | 187.76 |
| NET Worth | 688.32 | 497.53 | 359.07 |
| Reserves and Surplus | 668.52 | 481.11 | 354.59 |
| Total Borrowing | 135.97 | 135.25 | 75.03 |
Key Performance Indicator
| Debt/Equity | 0.2 |
| RoNW | 27.88 |
| PAT Margin | 27.63 |
| EBITDA Margin | 39.7 |
| Price to Book Value | 12.93 |
| Market Capitalization | 6697.85 |
Information about company
Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries.
The company operates six manufacturing facilities with a combined production capacity of 50,000 MT, specializing in minerals such as calcium, iron, magnesium, zinc, potassium, and sodium
The company supplies more than 200 products to a diverse customer base across pharma, food, and nutrition sectors
The company has strong R&D capabilities with in-house labs and pilot-scale facilities focused on mineral salts and excipients.
Product Portfolio:
Pharmaceutical, Food and Nutrition Business
Specialty Ingredients Business
Triturates
As of December 31, 2024, the company had 704 permanent employees.
Competitve Strengths:
Market leadership with a diversified product portfolio in a high barrier industry
Distinguished global customer base with long-standing relationships with key customers
Well-equipped and regulatory compliant Manufacturing Facilities
Strong research and development capabilities
Objectives of IPO
The Company Sudeep Pharma IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
S.No.
Objects of the Issue
Expected Amount (₹ in crores)
1
Capital expenditure towards procurement of machinery for the production line located at Nandesari Facility I
75.81
2
General corporate purposes
12.67
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App
Day Wise Sub
| Day 1
Nov 21, 2025 | 0.09 | 3.01 | 2.75 | 3.53 | 1.53 | 1.43 |
| Day 2
Nov 24, 2025 | 0.13 | 12.03 | 10.99 | 14.11 | 5.02 | 5.13 |
| Day 3
Nov 25, 2025 | 213.08 | 116.72 | 134.91 | 80.33 | 15.65 | 93.71 |
Day Wise GMP
| 28-11-2025 | 593.00 | 121(20.40%) | 714 |
| 27-11-2025 | 593.00 | 121(20.40%) | 714 |
| 26-11-2025 | 593.00 | 97(16.36%) | 690 |
| 25-11-2025 | 593.00 | 86(14.50%) | 679 |
| 24-11-2025 | 593.00 | 90(15.18%) | 683 |
| 23-11-2025 | 593.00 | 121(20.40%) | 714 |
| 22-11-2025 | 593.00 | 113(19.06%) | 706 |
| 21-11-2025 | 593.00 | 115(19.39%) | 708 |
| 20-11-2025 | 593.00 | 122(20.57%) | 715 |
| 19-11-2025 | 593.00 | 130(21.92%) | 723 |
| 18-11-2025 | 593.00 | 93(15.68%) | 686 |
| 17-11-2025 | | 0(%) | (%) |
IPO Reservation
| QIB Shares Offered | 75,46,373 (50.00%) | NA |
| − Anchor Investor Shares Offered | 45,27,823 (30.00%) | NA |
| − QIB (Ex. Anchor) Shares Offered | 30,18,550 (20.00%) | NA |
| NII (HNI) Shares Offered | 22,63,913 (15.00%) | NA |
| − bNII > ₹10L | 15,09,276 (10.00%) | 4,312 |
| − sNII < ₹10L | 7,54,637 (5.00%) | 2,156 |
| Retail Shares Offered | 52,82,463 (35.00%) | 2,11,298 |
| Total Shares Offered | 1,50,92,749 (100.00%) | |
